MIRM
Mirum Pharmaceuticals Inc.
Latest News for MIRM
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA), Fate Therapeutics (FATE) ......
Mirum Pharmaceuticals received a Buy rating and an $115.00 price target from J.P. Morgan analyst today. The word on The Street in general, suggests......
Mirum Pharmaceuticals ( ($MIRM) ) just unveiled an announcement. On May 15, 2026, Mirum Pharmaceuticals issued $690 million of 0.00% Convertible Se......
In a report released today, Mani Foroohar from Leerink Partners maintained a Buy rating on Mirum Pharmaceuticals, with a price target of $154.00. A......
In a report released today, Swayampakula Ramakanth from H.C. Wainwright assigned a Buy rating to Mirum Pharmaceuticals, with a price target of $185......
In a report released today, Lisa Walter from RBC Capital maintained a Buy rating on Mirum Pharmaceuticals, with a price target of $142.00. Accordin......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InflaRx (IFRX) and Mirum Pharmaceuticals (MIRM) with......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InflaRx (IFRX) and Mirum Pharmaceuticals (MIRM) with......
The latest announcement is out from Mirum Pharmaceuticals ( ($MIRM) ). On May 4, 2026, Mirum Pharmaceuticals reported that its VISTAS Phase 2b tria......
News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MIRM | $99.72 | +1.1% | 330.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mirum Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW